Review
Statin myopathy: A common dilemma not reflected in clinical trials
Genaro Fernandez, MD, Erica S. Spatz, MD, Charles Jablecki, MD and Paul S. Phillips, MD
Cleveland Clinic Journal of Medicine June 2011, 78 (6) 393-403; DOI: https://doi.org/10.3949/ccjm.78a.10073
Genaro Fernandez
Internal Medicine Residency Program, The University of Utah, Salt Lake City
Erica S. Spatz
Robert Wood Johnson Clinical Scholars Program, Cardiovascular Disease Fellow, Yale University School of Medicine, New Haven, CT
Charles Jablecki
Department of Neurosciences, University of California San Diego, La Jolla
Paul S. Phillips
Director, Interventional Cardiology, Department of Cardiology, Scripps Mercy Hospital, San Diego, CA
In this issue
Cleveland Clinic Journal of Medicine
Vol. 78, Issue 6
1 Jun 2011
Statin myopathy: A common dilemma not reflected in clinical trials
Genaro Fernandez, Erica S. Spatz, Charles Jablecki, Paul S. Phillips
Cleveland Clinic Journal of Medicine Jun 2011, 78 (6) 393-403; DOI: 10.3949/ccjm.78a.10073
Jump to section
Related Articles
- No related articles found.
Cited By...
- Drug-induced cytotoxicity prediction in muscle cells, an application of the Cell Painting assay
- Statins for the primary prevention of cardiovascular disease: an overview of systematic reviews
- Statin Therapy as Primary Prevention in Exercising Adults: Best Evidence for Avoiding Myalgia
- The Case For and Against a Coronary Artery Calcium Trial: Means, Motive, and Opportunity
- Statin therapy in patients with cirrhosis
- Rhabdomyolysis: Pathogenesis, Diagnosis, and Treatment
- Experimental Nonalcoholic Steatohepatitis Increases Exposure to Simvastatin Hydroxy Acid by Decreasing Hepatic Organic Anion Transporting Polypeptide Expression
- Perspective on the 2013 American Heart Association/American College of Cardiology Guideline for the Use of Statins in Primary Prevention of Low-Risk Individuals
- Authors' reply to Huffman and colleagues
- Proximal myopathy: diagnostic approach and initial management
- Comparative Tolerability and Harms of Individual Statins: A Study-Level Network Meta-Analysis of 246 955 Participants From 135 Randomized, Controlled Trials
- Reinitiation of Statins After Statin-Associated Musculoskeletal Symptoms: A Patient-Centered Approach